FI941628A0 - A mixture to stop bleeding locally - Google Patents

A mixture to stop bleeding locally

Info

Publication number
FI941628A0
FI941628A0 FI941628A FI941628A FI941628A0 FI 941628 A0 FI941628 A0 FI 941628A0 FI 941628 A FI941628 A FI 941628A FI 941628 A FI941628 A FI 941628A FI 941628 A0 FI941628 A0 FI 941628A0
Authority
FI
Finland
Prior art keywords
locally
mixture
stop bleeding
bleeding
stop
Prior art date
Application number
FI941628A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI941628A (en
Inventor
Ulla Karin Elisabeth Hedner
Erik Oestergaard
Martin William Edvards
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of FI941628A0 publication Critical patent/FI941628A0/en
Publication of FI941628A publication Critical patent/FI941628A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/108—Specific proteins or polypeptides not covered by groups A61L24/102 - A61L24/106
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0047—Specific proteins or polypeptides not covered by groups A61L26/0033 - A61L26/0042
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding
FI941628A 1991-10-11 1994-04-08 Composition for local hemostasis FI941628A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77566491A 1991-10-11 1991-10-11
PCT/DK1992/000296 WO1993006855A1 (en) 1991-10-11 1992-10-09 Hemostatic composition for local hemostasis

Publications (2)

Publication Number Publication Date
FI941628A0 true FI941628A0 (en) 1994-04-08
FI941628A FI941628A (en) 1994-06-08

Family

ID=25105103

Family Applications (1)

Application Number Title Priority Date Filing Date
FI941628A FI941628A (en) 1991-10-11 1994-04-08 Composition for local hemostasis

Country Status (9)

Country Link
EP (1) EP0613377A1 (en)
JP (1) JPH07500095A (en)
AU (1) AU2793292A (en)
CA (1) CA2121028A1 (en)
CZ (1) CZ83194A3 (en)
FI (1) FI941628A (en)
HU (1) HUT67693A (en)
NO (1) NO941285L (en)
WO (1) WO1993006855A1 (en)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2175203A1 (en) * 1993-11-03 1995-05-11 Thaddeus P. Pruss Hemostatic patch
DE19903693A1 (en) * 1998-04-24 1999-10-28 Centeon Pharma Gmbh Protease for activation of coagulation factor VII
FR2754183A1 (en) * 1996-10-08 1998-04-10 Lefebvre Jean Marie VISCOUS HEMOSTATIC COMPOSITION, IN PARTICULAR IN THE CONDITION OF FROST
DE19710190A1 (en) * 1997-03-12 1998-09-17 Immuno Ag Activated vitamin K-dependent blood factor and method for its production
AU7907398A (en) * 1997-06-23 1999-01-04 Novo Nordisk A/S Use of fviia for the treatment of bleedings in patients with a normal blood clotting cascade and normal platelet function
KR100821644B1 (en) * 1999-07-14 2008-04-11 노보 노르디스크 헬스 케어 악티엔게젤샤프트 USE OF FVIIa OR A TISSUE FACTOR ANTAGONIST FOR REGULATING GENE EXPRESSION AND CELL MIGRATION OR CHEMOTAXIS
GB0011053D0 (en) 2000-05-09 2000-06-28 Hudson John O Medical device and use thereof
DE60112429T2 (en) * 2000-05-10 2006-06-01 Novo Nordisk Health Care Ag USE OF FACTOR VII-A AND FACTOR XIII-CONTAINING PHARMACEUTICAL COMPOUNDS
US7015194B2 (en) 2000-05-10 2006-03-21 Novo Nordisk A/S Pharmaceutical composition comprising factor VIIa and anti-TFPI
EP1190724B8 (en) * 2000-09-22 2006-05-03 Perlei Medical Produkte GmbH Use of antifibrinolytic agents for preparing sponges, compresses or dressings
WO2003039582A1 (en) * 2001-11-09 2003-05-15 Novo Nordisk Health Care Ag Pharmaceutical composition comprising a factor vii polypeptide and epsilon-aminocapronic acid
US7078479B2 (en) 2001-11-09 2006-07-18 Novo Nordisk Healthcare A/G Pharmaceutical composition comprising factor VII polypeptides and alpha2-antiplasmin polypeptides
JP2005508985A (en) * 2001-11-09 2005-04-07 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト Pharmaceutical composition comprising a Factor VII polypeptide and an aprotinin polypeptide
US7291587B2 (en) 2001-11-09 2007-11-06 Novo Nordisk Healthcare A/G Pharmaceutical composition comprising factor VII polypeptides and TAFI polypeptides
EP1446147A1 (en) * 2001-11-09 2004-08-18 Novo Nordisk Health Care AG Pharmaceutical composition comprising factor vii polypeptides and tranexamic acid
US7125846B2 (en) 2001-11-09 2006-10-24 Novo Nordisk Healthcare A/G Pharmaceutical composition comprising factor VII polypeptides and factor V polypeptides
WO2003039579A1 (en) 2001-11-09 2003-05-15 Novo Nordisk Health Care Ag Pharmaceutical composition comprising factor vii polypeptides and tafi polypeptides
GB2409162B (en) * 2004-10-06 2005-12-14 Bhk Holding Ltd Materials,methods,and apparatus for treating a body cavity
AR048742A1 (en) * 2004-12-22 2006-05-24 Gador Sa INTRA-ORAL MEDICINES APPLICATION SYSTEM
FR2894831B1 (en) * 2005-12-16 2008-02-15 Lab Francais Du Fractionnement THROMBIN FREE BIOLOGICAL GLUE AND USE THEREOF AS MEDICAMENT.
WO2007104317A1 (en) * 2006-03-16 2007-09-20 Drugrecure Aps Methods for local treatment with factor vii
GB2447012B (en) * 2007-02-21 2011-03-16 Pharmacure Health Care Ab Composition for combating epistaxis
US8642831B2 (en) 2008-02-29 2014-02-04 Ferrosan Medical Devices A/S Device for promotion of hemostasis and/or wound healing
ES2421642T3 (en) * 2008-03-03 2013-09-04 Omrix Biopharmaceuticals Ltd A jelly sponge comprising an active ingredient, its preparation and use
RU2501556C2 (en) * 2011-10-06 2013-12-20 Владимир Лазаревич Адамян Heamostatic match
WO2013131520A2 (en) 2012-03-06 2013-09-12 Ferrosan Medical Devices A/S Pressurized container containing haemostatic paste
RU2636240C2 (en) 2012-06-12 2017-11-21 Ферросан Медикал Дивайсиз А/С Dry haemostatic composition
JP6390873B2 (en) 2013-06-21 2018-09-19 フェッローサン メディカル ディバイス エー／エス Dry composition expanded under reduced pressure and syringe for holding the same
RU2678592C1 (en) 2013-12-11 2019-01-30 Ферросан Медикал Дивайсиз А/С Dry composition comprising extrusion enhancer
BR112017007466B1 (en) 2014-10-13 2021-03-02 Ferrosan Medical Devices A/S method for preparing a dry composition, method for reconstituting the dry composition, paste, dry composition, container, homeostatic kit, and, using a dry composition
JP6747650B2 (en) 2014-12-24 2020-08-26 フェロサン メディカル デバイシーズ エイ／エス Syringe for holding and mixing the first substance and the second substance
US10918796B2 (en) 2015-07-03 2021-02-16 Ferrosan Medical Devices A/S Syringe for mixing two components and for retaining a vacuum in a storage condition
WO2017037178A1 (en) * 2015-09-01 2017-03-09 Trauma Care Consult Traumatologische Forschung Gemeinnützige Gesellschaft Mbh Hemostatic material
KR20210008479A (en) 2018-05-09 2021-01-22 훼로산 메디칼 디바이스 에이/에스 How to prepare a hemostatic composition
US20230001048A1 (en) * 2019-12-25 2023-01-05 Guangzhou Bioseal Biotech Co., Ltd. Hemostatic paste and uses thereof
WO2024042148A1 (en) 2022-08-26 2024-02-29 Stellaris Pharmaceuticals Aps Haemorrhage inhibiting compositions and methods involving the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4382083A (en) * 1981-06-25 1983-05-03 Baxter Travenol Laboratories, Inc. Therapeutic method for treating blood-clotting defects with factor VIIa
ATE66374T1 (en) * 1985-11-26 1991-09-15 Novo Nordisk As PREPARATIONS AND METHODS FOR TREATMENT OF BLOOD DISORDERS.

Also Published As

Publication number Publication date
FI941628A (en) 1994-06-08
CZ83194A3 (en) 1994-11-16
CA2121028A1 (en) 1993-04-15
AU2793292A (en) 1993-05-03
WO1993006855A1 (en) 1993-04-15
JPH07500095A (en) 1995-01-05
EP0613377A1 (en) 1994-09-07
NO941285D0 (en) 1994-04-08
NO941285L (en) 1994-06-07
HU9401008D0 (en) 1994-07-28
HUT67693A (en) 1995-04-28

Similar Documents

Publication Publication Date Title
FI941628A0 (en) A mixture to stop bleeding locally
DK44389D0 (en) SYNERGIC ANTIOXIDANT MIXTURE
BR9205781A (en) Composition process to produce the composition
KR900011269A (en) How to perform multi-screen
NO933800D0 (en) Particulate detergent mixture
BR8901146A (en) PA TO HELICE CARENADA
FI103666B (en) A process for the preparation of a biphenyl derivative
DE69229332T2 (en) Positive working resist composition
KR900006817A (en) Resist composition
MX9203919A (en) PROCEDURE TO PURIFY ORGANOPOLISILOXANES.
DE69209356D1 (en) Positive working resist composition
DE69223083D1 (en) Positive working resist composition
BR7002423U (en) CONSTRUCTIVE ARRANGEMENT APPLIED TO LACRE
DE69213996T2 (en) Positive working resist composition
GB2256420B (en) Improvements relating to fibre-wound structures
BR7100634U (en) PROVISION PROVIDED TO TECHADURA
BR7101923U (en) PROVISION PROVIDED TO ABACO
BR9101347A (en) MACHINE TO MAKE SNACKS
BR7100729U (en) PROVISION PROVIDED TO THE TRAILER STRUCTURE
BR7101317U (en) ARRANGEMENT PROVIDED TO POCKETKNIVES
BR6900532U (en) CONSTRUCTIVE ARRANGEMENT APPLIED TO BUCKLE
BR7201288U (en) PROVISION PROVIDED TO SEMATORO
BR7100021U (en) CONSTRUCTIVE ARRANGEMENT APPLIED TO CASH-ARCHIVE
DE69214363T2 (en) Abutment button
BR7100539U (en) CONSTRUCTIVE ARRANGEMENT APPLIED TO AUTOMATIC BRICK CUTTER

Legal Events

Date Code Title Description
FD Application lapsed